ENTITY
SK Bioscience

SK Bioscience (302440 KS)

165
Analysis
Health CareSouth Korea
SK Bioscience Co.,Ltd. operates biopharmaceutical businesses. The Company produces vaccines, sky cellflu prefilled syringes, sky cellflu quadrivalent prefilled syringes, varicella drugs, and other related products. SK Bioscience markets its products throughout South Korea.
more
Refresh
06 Apr 2021 09:19

KOSPI 200 Rebalancing: SK BioS/SK IET Fast Entry & LG Corp New Entity (8 Added & 9 Deleted)

This post tracks the KOSPI 200 June review based on the average daily MC as of April 5. We have 8 additions, incl. SK BioS/SK IET fast entry as...

Logo
285 Views
Share
bullishSK Bioscience
06 Apr 2021 07:34

SK Bioscience IPO: KOSPI200 Fast Entry Guaranteed; SGBC Most Likely Deletion

SK Bioscience's Fast Entry into the KOSPI200 Index is almost guaranteed. We see SGBC as the most likely deletion. With a lot of shares still locked...

Logo
311 Views
Share
01 Apr 2021 20:28

SK IET IPO Preview

SK IET plans to complete its IPO in May.  The IPO price range is from 78,000 won to 105,000 won. The IPO base deal size is from $1.5 billion to...

Logo
569 Views
Share
bullishSK Bioscience
01 Apr 2021 10:47

SK Bioscience: K200 Fast Entry, Lock-Up Expiry, Loan/Short Balance, & Exit Points

This post checks the current situation of SK Bioscience on K200 fast entry, lock-up expiry, loan/short balance, and potential exit points.

Logo
473 Views
Share
bullishSK Bioscience
21 Mar 2021 01:52

What Happened to SK Bioscience on Day 2 (Feat. Kyobo Securities)?

This post looks at the suspicious activities seen at the Kyobo account on SK Biosciences' Day 1 and Day 2 and what it can mean for the price in the...

Logo
301 Views
Share
x